Patient Validation of Estimation of Health Utility Values in Alopecia Areata
This is the first known study to evaluate how patients with AA would make trade-offs between quantity of life and disease-specific quality of life. A high willingness to trade off duration of life was observed, consistent with the UK public study and supporting a high disease burden of AA.
Authors
- Andrew Lloyd (ORCID: https://orcid.org/0000-0002-7597-6556)
- Ernest H. Law (ORCID: https://orcid.org/0000-0002-6111-8008)
- Elin Gruffydd
- Thomas M Price (ORCID: https://orcid.org/0000-0003-1888-306X)
- Caleb Dixon (ORCID: https://orcid.org/0000-0002-7268-2130)
Institutions
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Lloyd's (GB)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1007/s41669-025-00576-0
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer